← All companies

ADXN

Addex Therapeutics Ltd

ADXN Nasdaq Pharmaceutical Preparations EDGAR ↗

$5.06

-0.14 -2.69%

Key statistics

from XBRL data in SEC filings

Market cap

$748M

Revenue (TTM)

—

Net income (TTM)

—

EPS (TTM)

—

P/E ratio

—

Dividend yield

—

Free cash flow

—

Cash

—

Total assets

—

Gross margin

—

52-week range

$5.04 – $12.05

Recent SEC filings

40 most recent

Annual, quarterly & current reports

6-K FORM 6-K Jul 8, 2026 6-K FORM 6-K Jun 30, 2026 6-K FORM 6-K Jun 25, 2026 6-K FORM 6-K Jun 5, 2026 20-F FORM 20-F May 15, 2026 6-K FORM 6-K Apr 30, 2026 6-K FORM 6-K Apr 29, 2026 6-K FORM 6-K Apr 23, 2026 6-K FORM 6-K Apr 21, 2026 6-K FORM 6-K Feb 3, 2026 6-K FORM 6-K Jan 7, 2026 6-K FORM 6-K Dec 10, 2025 6-K FORM 6-K Dec 4, 2025 6-K FORM 6-K Oct 29, 2025 6-K FORM 6-K Sep 30, 2025 6-K FORM 6-K Sep 23, 2025 6-K FORM 6-K Jun 30, 2025 6-K FORM 6-K Jun 25, 2025 6-K FORM 6-K Jun 20, 2025 6-K FORM 6-K Jun 6, 2025 20-F FORM 20-F May 15, 2025 6-K FORM 6-K May 12, 2025 6-K FORM 6-K Apr 30, 2025 6-K FORM 6-K Apr 25, 2025 6-K FORM 6-K Apr 17, 2025 6-K FORM 6-K Nov 22, 2024 6-K FORM 6-K Nov 12, 2024 6-K FORM 6-K Sep 30, 2024 6-K FORM 6-K Sep 19, 2024 6-K FORM 6-K Aug 27, 2024 6-K FORM 6-K Jul 22, 2024 6-K FORM 6-K Jul 15, 2024 6-K FORM 6-K Jul 1, 2024 6-K FORM 6-K Jun 6, 2024 6-K FORM 6-K Jun 5, 2024 6-K FORM 6-K Apr 29, 2024 20-F FORM 20-F Apr 18, 2024 6-K FORM 6-K Apr 18, 2024 6-K FORM 6-K Apr 3, 2024 6-K FORM 6-K Jan 30, 2024